204 related articles for article (PubMed ID: 35202913)
1. Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat.
Sung PH; Chai HT; Yang CC; Chiang JY; Chen CH; Chen YL; Yip HK
Biomed Pharmacother; 2022 Apr; 148():112745. PubMed ID: 35202913
[TBL] [Abstract][Full Text] [Related]
2. Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity.
Yeh JN; Yue Y; Chu YC; Huang CR; Yang CC; Chiang JY; Yip HK; Guo J
Biomed Pharmacother; 2021 Dec; 144():112244. PubMed ID: 34601193
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy with dapagliflozin and entresto offers an additional benefit on improving the heart function in rat after ischemia-reperfusion injury.
Ko SF; Sung PH; Yang CC; Chiang JY; Yip HK
Biomed J; 2023 Jun; 46(3):100546. PubMed ID: 35718305
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet.
Yang CC; Chen YT; Chen CH; Li YC; Shao PL; Huang TH; Chen YL; Sun CK; Yip HK
Biomed Pharmacother; 2019 Aug; 116():108954. PubMed ID: 31108352
[TBL] [Abstract][Full Text] [Related]
5. Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat.
Yang CC; Chen YT; Wallace CG; Chen KH; Cheng BC; Sung PH; Li YC; Ko SF; Chang HW; Yip HK
Biomed Pharmacother; 2019 Jan; 109():658-670. PubMed ID: 30404073
[TBL] [Abstract][Full Text] [Related]
6. The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome.
Chua S; Lee FY; Chiang HJ; Chen KH; Lu HI; Chen YT; Yang CC; Lin KC; Chen YL; Kao GS; Chen CH; Chang HW; Yip HK
J Pineal Res; 2016 Nov; 61(4):438-456. PubMed ID: 27465663
[TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin-entresto protected kidney from renal hypertension via downregulating cell-stress signaling and upregulating SIRT1/PGC-1α/Mfn2-medicated mitochondrial homeostasis.
Ko SF; Yang CC; Sung PH; Cheng BC; Shao PL; Chen YL; Yip HK
Exp Biol Med (Maywood); 2023 Dec; 248(23):2421-2439. PubMed ID: 38059322
[TBL] [Abstract][Full Text] [Related]
8. Early treatment with combination of SS31 and entresto effectively preserved the heart function in doxorubicin-induced dilated cardiomyopathic rat.
Yeh JN; Sung PH; Chiang JY; Sheu JJ; Huang CR; Chu YC; Chua S; Yip HK
Biomed Pharmacother; 2021 Sep; 141():111886. PubMed ID: 34426177
[TBL] [Abstract][Full Text] [Related]
9. Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness.
Aroor AR; Mummidi S; Lopez-Alvarenga JC; Das N; Habibi J; Jia G; Lastra G; Chandrasekar B; DeMarco VG
Cardiovasc Diabetol; 2021 Apr; 20(1):80. PubMed ID: 33882908
[TBL] [Abstract][Full Text] [Related]
10. Prion Protein Overexpression in Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Effectively Protected Rodent Kidney Against Ischemia-Reperfusion Injury Via Enhancing ATP/Mitochondrial Biogenesis-Role of ADMSC Rejuvenation and Proliferation.
Chen YT; Yang CC; Chiang JY; Sung PH; Shao PL; Huang CR; Lee MS; Yip HK
Cell Transplant; 2023; 32():9636897231211067. PubMed ID: 38078417
[TBL] [Abstract][Full Text] [Related]
11. Combined Therapy with SS31 and Mitochondria Mitigates Myocardial Ischemia-Reperfusion Injury in Rats.
Lee FY; Shao PL; Wallace CG; Chua S; Sung PH; Ko SF; Chai HT; Chung SY; Chen KH; Lu HI; Chen YL; Huang TH; Sheu JJ; Yip HK
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223594
[TBL] [Abstract][Full Text] [Related]
12. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction.
Shi YJ; Yang CG; Qiao WB; Liu YC; Liu SY; Dong GJ
Eur J Pharmacol; 2023 Dec; 961():176170. PubMed ID: 37939991
[TBL] [Abstract][Full Text] [Related]
13. Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.
Raj P; Sayfee K; Parikh M; Yu L; Wigle J; Netticadan T; Zieroth S
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443591
[TBL] [Abstract][Full Text] [Related]
14. Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in
Myakala K; Jones BA; Wang XX; Levi M
Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1133-F1151. PubMed ID: 33870733
[TBL] [Abstract][Full Text] [Related]
15. Sacubitril/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEF.
Schauer A; Adams V; Augstein A; Jannasch A; Draskowski R; Kirchhoff V; Goto K; Mittag J; Galli R; Männel A; Barthel P; Linke A; Winzer EB
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808232
[TBL] [Abstract][Full Text] [Related]
16. Impact of One Versus Two Consecutive Doses of Endothelial Cells (EPCs) and EPCs-Derived Condition Medium on Protecting Myocardium from Acute Ischemia-Reperfusion Injury in Rat.
Yeh JN; Yang RR; Wallace CG; Huang CR; Chu YC; Yip HK; Guo J
Cell Transplant; 2021; 30():9636897211007049. PubMed ID: 33975445
[TBL] [Abstract][Full Text] [Related]
17. Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes for protecting kidney from acute ischemia-reperfusion injury.
Lin KC; Yip HK; Shao PL; Wu SC; Chen KH; Chen YT; Yang CC; Sun CK; Kao GS; Chen SY; Chai HT; Chang CL; Chen CH; Lee MS
Int J Cardiol; 2016 Aug; 216():173-85. PubMed ID: 27156061
[TBL] [Abstract][Full Text] [Related]
18. [Sacubitril/valsartan attenuates left ventricular remodeling and improve cardiac function by upregulating apelin/APJ pathway in rats with heart failure].
Liu HZ; Gao CY; Yuan F; Xu Y; Tian H; Wang SQ; Zhang PF; Shi YN; Wei JJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):690-697. PubMed ID: 35856226
[No Abstract] [Full Text] [Related]
19. Melatonin pretreatment enhances the therapeutic effects of exogenous mitochondria against hepatic ischemia-reperfusion injury in rats through suppression of mitochondrial permeability transition.
Chen HH; Chen YT; Yang CC; Chen KH; Sung PH; Chiang HJ; Chen CH; Chua S; Chung SY; Chen YL; Huang TH; Kao GS; Chen SY; Lee MS; Yip HK
J Pineal Res; 2016 Aug; 61(1):52-68. PubMed ID: 26993080
[TBL] [Abstract][Full Text] [Related]
20. Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits.
Torrado J; Cain C; Mauro AG; Romeo F; Ockaili R; Chau VQ; Nestler JA; Devarakonda T; Ghosh S; Das A; Salloum FN
J Am Coll Cardiol; 2018 Nov; 72(19):2342-2356. PubMed ID: 30384891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
